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ABSTRACT 
 
Rheumatoid arthritis and depression commonly concur. Although this is often known, people with arthritis 
often aren't diagnosed for depression, so it's not going to be treated. The main aim of the work is to evaluate 
the remission of pain and estimate intensity of depression in rheumatoid arthritis patients. We collected 40 
cases of RA at VIRRD hospital and collected the details. By using Visual analogue scale we have estimated 
the pain remission and by using Beck Depression Inventory we evaluated intensity of depression. This study 
shows the Adults (Above 18 years) are affected more with RA than that of other age groups. This study 
reveals that people affected with RA are 80% of female. So that females are more affected. As chronic pain 
is the important symptom of RA we evaluated the remission of pain. We observed there is decrease in pain 
after using the medication which indicates that there is remission of pain in patients when they are on reg-
ular treatment. This study showed a strong relation between RA and succeeding risk of depression. Based 
on the study almost 62.5% RA patients have some level of depression. We suggest that for optimal care and 
better outcomes of RA patient, it is important to detect and treat depression based on their level as there is 
some level of depression in RA patient. 
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INTRODUCTION 
RA is a long – term autoimmune disease that can 
cause joint pain and damage throughout your body 
which results in severe disabilities and deformities. It 
occurs when your own immune system attacks the 
liner of the membranes that surround your joints 
(synovium). Symptoms in RA include Stiffness, Swell-
ing, Pain, Fatigue, fever and weight loss, Redness and 
warmth. 
The generality of RA is comparatively constant in 
many populations, at 0.5-1.0% worldwide. However, 
a high generality of RA has been according within the 
Pima Indians (5.3%) and within the Chippewa Indi-
ans (6.8%). In distinction, low occurrences square 
measures according in population from china and Ja-
pan. This information supports a genetic role in sick-
ness risk. Studies have to this point shown that the fa-
milial return in RA is small compared with different 
reaction diseases. The symptoms like inflammation, 
swelling and joint harm that characterize active RA 
square measure the top results of advanced reaction 
and inflammatory process that involves parts of each 
the innate and reconciling immune systems. In an ex-
ceedingly vulnerable individual, the interaction of 
genes ends up in a loss of tolerance of self-proteins 
that contain a citrulline residue. These proteins 
square measure generated via post travel alteration 
of essential amino acid residues to aminoalkanoic 
residues by the catalyst peptidyl arginine deiminase 
[1].Patients with shared epitopes create citrullinated 
peptides that are not any longer admit as “self” by the 
system that consequently develops ACPAs against 
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them[2].Comparison of resonance imaging MRI and 
secretion diagnostic test information from healthy 
people with MRI and diagnostic test information from 
patients positive for RA and/or ACPA reveal that gen-
eral anti body production precedes inflammation and 
adhesion molecule formation inside the tissue layer, 
indicating that may be some secondary event is 
needed to initiate involvement of the tissue layer in 
RA[3].The inside of the inflamed tissue layer (syno-
vium) is hypoxic, presumptively as a results of prolif-
eration of secretion cells and depletion in secretion 
capillary flow a result of raised fluid volume within 
the synovium[4].Hypoxia, in turn, stimulates growing 
within the tissue layer, may be incentive the for-
mation of things that stimulate vessel formation like 
vascular epithelium growth factor[5] . The significance 
of the reconciling immune pathway in RA is recom-
mended by the presence of nerve fibre cells (den-
dritic cells), a important category of antigen- present-
ing cells that express a spread of cytokines, HLA cate-
gory II molecules, and costimulatory molecules in 
shut proximity to cluster of T cells within the tissue 
layer and additionally function one element of T cell 
and activation method [6]. Activation of T cells needs a 
pair of signals. The primary signal is antigen presen-
tation to the T-cell receptor. The second signal, the 
costimulatory signal, needs interaction of the surface 
macromolecule CD80/86 on the antigen presenting 
(dendritic) cell with CD28 macromolecule on the lym-
phocyte [7]. Blockade of the costimulatory signal 
through competitive inhibition of CD80/86 interferes 
with T-cell activation and downstream events. The ef-
fectiveness of CD80/86 blockade as a treatment for 
RA validates the thought that T cell play a full of life 
role within the pathophysiology of RA [8].         
In particular, a small change in gene expression in im-
mune cells is frequently associated with production 
and secretion of inflammatory mediators in response 
to a particular stimulus. Secretion of those mediators 
into the extracellular milieu leads to further amplifi-
cation and/or modification of the first signal. 
Risk factors include Age, Family history, Environ-
ment, Gender, Obesity, Smoking.  
Complications include Sjogren’s syndrome, rheuma-
toid nodules, Pericarditis, Vasculitis, Pleuritis, COPD, 
Scleritis, Sexual dysfunction. 
Diagnosed by Physical Examination, Blood Tests for 
antibodies linked with RA, Erythrocyte sedimenta-
tion rate (ESR) and C-reactive protein (CRP) level are 
markers of inflammation, Antibodies Rheumatoid 
factor (RF) anti-cyclic citrullinated peptide (anti-
CCP) occurs primarily in patients with RA, Imaging 
Tests X-ray. 
Treatment: Patients with RA are not tested for de-
pression and hence they are not treated. It is not clear 
whether are not depression and anxiety in RA pa-
tients are a result of their physical symptoms, or if de-
pression is however an additional symptom gives rise 
to chronic, systemic inflammation of RA [9]. 
MATERIALS AND METHODS 
This project is completed at Sri Venkateswara insti-
tute of research and rehabilitation for the disabled 
(VIRRD) hospital Timmapuram village, Dwaraka 
Tirumala mandel, Andhra Pradesh, under the guid-
ance of Dr. Bhavya Chand (Ms, Ortho). 
To evaluate the remission of pain: The measure-
ment of remission of pain is done by using VAS [10]. 
Visual analogue scale: 
The visual analogue scale (VAS) may be a psycholog-
ical response scale which may be employed in ques-
tionnaires. It’s a measurement instrument for subjec-
tive attitude that cannot be directly measured. The 
primary and presumptively used scale in hospitals 
for assessing adult and old verbal adults to assess the 
pain is known as Wong – baker faces scale [11]. 
 
Figure 1: Visual analogue scale 
This scale goes from zero (No pain) to Ten (The worst 
pain) you’ll imagine. It indicates some facial expres-
sions that are simplified facial expressions that will 
facilitate a patient however they need bother 
properly distinguishing the extent of pain.  
 
Figure 2: VAS indicating Type of Pain 
The above image indicates type of pain. The patient 
pain is scored from 0 no pain to 10 worst pains based 
on their facial expressions. Score is used to indicate 
the intense of pain in particular patient. 
To estimate the intensity of depression 
The BDI is also a series of questions developed to 
measure the intensity, severity, and depth of depres-
sion in patients with psychiatric diagnoses. The 
long style of the BDI consists of twenty one quires 
every with four possible responses. Each response is 
appointed a score starting from zero to three, indicat-
ing the severity of symptom. Individual questions of 
the BDI assess mood, pessimism, and sense of failure, 
self-dissatisfaction, guilt, punishment, self-dislike, 
self-accusation, self-destructive concepts, crying, irri-
tability, social withdrawal, body image, work difficul-
ties, insomnia, fatigue, appetite, weight loss, bodily 
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preoccupation, and loss of concupiscence. Things one 
to thirteen assess symptoms that are psychological in 
nature, whereas things to fourteen to twenty one as-
sess additional physical symptoms [12]. 
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Table 1: BDI Scale 
Sl.No Questioner Options 
1 I don’t feel unhappy 
I feel sad. 
I’m unhappy all the time and that I can’t snap out of it. 
I’m therefore unhappy and sad that I can’t stand it. 
2 
I’m not significantly dis-
couraged regarding the 
long term. 
I feel discouraged regarding the long term. 
I feel I even have nothing to appear forward to. 
I feel the time to return is hopeless that things cannot improve. 
3 
I don’t desire a failure. 
 
I feel I even have failing quite the standard person. 
As I think back on my life, all I will see could also be heaps of failures. 
I feel I’m complete failure as someone. 
4 
I get the utmost amount 
satisfaction out of things 
as accustomed. 
I don’t relish things the manner I accustomed. 
I don’t get real satisfaction out of something any longer. 
I’m disgruntled of everything 
5 
I don’t feel significantly 
guilty. 
I feel guilty a decent a part of the time. 
I feel quite guilty most of the time. 
I feel guilty all the time. 
6 
I don’t feel I’m being pun-
ished. 
I feel I could be punished. 
I expected to be punished. 
I feel I’m being punished 
7 
I don’t feel unsuccessful 
in myself. 
I’m disappointed in myself. 
I’m tired of with myself. 
I hate myself. 
8 
I don’t feel I’m worse 
than anybody else. 
I’m important of myself for my weakness or mistakes. 
I blame myself all the time for my faults. 
I blame myself for everything dangerous that happens. 
9 
I don’t have any thoughts 
of killing myself. 
I even have thoughts of killing myself, however I’d not carry them out. 
I might prefer to kill myself. 
I’d kill myself if I had the prospect. 
10 
I don’t cry any further 
than usual. 
I cry a lot of currently than before. 
I cry all the time currently. 
I accustomed be able to cry, however currently I can’t cry albeit I might prefer to. 
11 
I’m a lot of irritated by 
things than I ever was. 
I’m slightly a lot of irritated currently than usual. 
I am quite irritated a decent deal of the time. 
I feel irritated all the time. 
12 
I even have not lost inter-
est in people. 
I’m less interested by individuals than i accustomed be. 
I even have lost most of my interest in individuals. 
I even have lost all my interest in people. 
13 
I make decisions about 
also as well as I ever 
could. 
I set back creating choices quite I accustomed. 
I even have larger problem in creating choices quite I accustomed. 
I can’t make decisions at all anymore. 
14 
I don’t feel that I look any 
worse than I accus-
tomed. 
I’m troubled than I am looking unattractive. 
I feel there are permanent changes in my look than create me looking unattractive. 
I think that I look ugly. 
15 
I can work out as well as 
before. 
I take an additional effort to urge started at doing one thing. 
I even have to penalise myself terribly onerous to try and do something. 
I can’t do any work at all. 
16 
I will sleep moreover as 
before. 
I don’t sleep moreover as I accustomed. 
I awaken 1-2 hours before usual and realize it onerous to urge back to sleep. 
I awaken many hours before I accustomed and can’t .go back to sleep. 
17 
I don’t get a lot of tired 
than usual. 
I get tired a lot of simply than I accustomed. 
I get tired from doing virtually something. 
I’m too tired to try and do something. 
18 
My carving isn’t any 
worse than usual. 
My carving isn’t pretty much as good because it accustomed be. 
My carving is way worse currently. 
I even have no carving in the slightest degree any longer. 
19 
I haven’t lost a lot of 
weight, if any, lately. 
I even have lost quite five pounds. 
I even have lost quite ten pounds. 
I even have lost quite fifteen pounds. 
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Based on the patient answer we score them as 0, 1, 2, 
or 3. The patients score is the sum of total items and 
are used to estimate the extension of depression [13]. 
Table 2: Estimation of Level of Depression 
Total 
score 
Levels of depression 
1-10 
The ups and downs are considered as nor-
mal 
11-16 Mild mood disturbance 
17-20 Borderline clinical depression 
21-30 Moderate depression 
31-40 Severe depression 
Over 40 Extreme depression 
Table 3: Data on Effect of RA Based on Age 
Age group No of patients 
1 – 10 0 
11 – 20 1 
21 – 30 6 
31 - 40 4 
41 - 50 13 
51 - 60 11 
61 - 70 5 
 
Figure 3: Effect of rheumatoid arthritis on Age 
Table 4: Data on Effect of RA Based on Gender 
Male Female 
8 32 
 
Figure 4: Effect of Rheumatoid Arthritis on Gender 
Table 5: Data of Pain Scales 
No of patients Age 
Pain scale 
First month Third month 
1 28 8 6 
2 41 6 3 
3 50 6 4 
4 45 7 5 
5 47 4 2 
6 43 8 6 
7 47 5 4 
8 59 5 4 
9 50 4 4 
10 29 5 2 
11 43 8 6 
12 23 7 5 
13 21 2 2 
14 40 4 3 
15 64 3 4 
16 55 5 4 
17 60 6 6 
18 52 6 5 
19 45 6 6 
20 40 8 6 
21 64 6 6 
22 30 3 3 
23 45 10 8 
24 55 5 4 
25 17 4 2 
26 66 9 6 
27 60 8 7 
28 60 3 2 
29 55 6 5 
30 35 8 7 
31 55 7 4 
32 65 7 5 
33 46 8 6 
34 68 5 2 
35 59 8 6 
36 40 6 4 
37 53 5 3 
38 26 6 4 
39 50 9 7 
40 43 8 7 
The data was analysed by using T paired Test and the 
results were generated. 
• Null hypothesis (H0): There is no pain remis-
sion in all patients. 
• Alternative hypothesis (H1): There is pain re-
mission in all patients. 
20 
I’m not a lot of troubled 
regarding my health than 
usual. 
I’m troubled regarding physical issues like aches, pains, constipation. 
I’m terribly troubled regarding physical issues and it’s onerous to believe of a lot of 
else. 
I’m therefore troubled regarding my physical issues that I cannot believe some-
thing. 
21 
I even have not noticed 
any recent change in my 
interest in sex. 
I’m less interested by sex than I accustomed. 
I even virtually no interest in sex. 
I even have lost interest in sex fully. 
 
Madhu Babu Mortha et al., (2020) Int. J. Res. Hos & Clin. Pharm., 2(2), 48-53 
Rubatosis Publications | International Journal of Research In Hospital and Clinical Pharmacy 53  
• Level of significance (LOS): 0.05% 
Table 6: Data analysis on remission of pain 
t-Test: Paired Two Sample for Means 
 Variable 1 Variable 2 
Mean 6.1 4.625 
Variance 3.579487179 2.804487179 
Observations 40 40 
Pearson Correlation 0.853789319  
Hypothesized Mean Dif-
ference 
0  
df 39  
t Stat 9.453778621  
P(T<=t) one-tail 6.126E-12  
t Critical one-tail 1.684875122  
P(T<=t) two-tail 1.2252E-11  
t Critical two-tail 2.022690901  
Comparision: Table value is more than the test value. 
Hence, it accepts the Alternative hypothesis and re-
jects the null hypothesis. Conclusion: The Alternative 
hypothesis (H0) indicates there is remission of pain 
in every patient. 
 
Figure 5: Area graph of pain remission 
The above graph shows pain scale values on y-axis and no of 
patients on x-axis. It indicates that there is reduction in pain 
after using medication. 
Table 7: Data of level of depression 
Type Level No of patients 
Normal 1 – 10 15 
Mild 11 – 16 9 
Boderline 17 – 20 7 
Moderate 21 – 30 3 
Severe 31 – 40 5 
Extreme Over 40 1 
 
Figure 6: Percentage of level of depression 
DISSCUSSION 
We have collected about 40 cases of patients, there 
details. This study shows the Adults (Above 18 years) 
are affected more with RA than that of other age 
groups. Most of the patients are at the age of 41 - 50 
years. 
Sex differs in the generality of RA. To assess the influ-
ence of gender in the quality of life of RA patients Fe-
male RA patients have lower quality of life levels than 
their male counter parts. This study reveals that peo-
ple affected with RA are 80% of female. So that fe-
males are highly affected than males. 
The intention of work is to estimate the remission of 
pain and evaluate the intensity of depression in rheu-
matoid arthritis patient. The remission of pain is esti-
mated by substantial decrease in symptom of pain by 
using VAS for assessment of impact of pain in RA pa-
tient. As chronic pain is the important symptom of RA. 
We used VAS to estimate pain and the outcome after 
using the medication. We monitored the total 40 pa-
tients for 3 months. We observed there is decrease in 
pain after using the medication which indicates that 
there is remission of pain in patients when they are 
on regular treatment. 
Depression is one of the major complications in RA 
patient. There was a strong association between RA 
and the level of depression. This study showed a 
strong relation between RA and future risk of depres-
sion. 
The main aim is to evaluate depression as it is highly 
prevalent in RA. Based on the study almost 62.5% RA 
patients have some level of depression. We suggest 
that for optimal care and better outcomes of RA pa-
tient, detection and control of depression is im-
portant. 
CONCLUSION 
Based on our study and discussion we concluded 
that: 
• Most of the patients are at age of 41 - 50years. 
• Females are highly affected than males. 
There is remission of pain and some level of depres-
sion in RA patients. As there is some level of depres-
sion in RA patient so we suggest that the treatment 
should be based on their levels that may include pa-
tient counselling and anti-depressants. 
The reasons supporting the above conclusion are: 
• Decreased in Pain scale from First month to 
Third month. 
• Some level depression in RA patients. 
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